Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Notable Bankruptcies Of 2009: Q3
Oct 05, 2009 09:06 AM |
AOG
,
ARG
,
AVR
,
BE
,
BKUNA
,
CAPE
Analyst Comments: ENSCO, Cosan, Eli Lilly, Research In Motion, Internap Network, PetroChina, Kinross Gold, HEICO, Canadian Pacific, AutoNation, Oscient Pharma, Equity Residential, Supertex
Oct 02, 2008 01:00 PM |
AN
,
CP
,
CZZ
,
EQR
,
ESV
,
HEI
MiddleBrook Fall Could Mean Opportunity
Aug 01, 2008 04:48 PM |
MBRK
,
OSCI
Analyst Comments: Vimpel, Magna, NewAlliance, Omnicom, Oscient Pharma, Robert Half, Penske
Jun 19, 2008 01:23 PM |
MBT
,
MGA
,
NAL
,
OMC
,
OSCI
,
PAG
Analyst Comments: Smith Micro, ValueClick, Cox Radio, Churchill Downs, NCR Corp, Myriad Genetics, Oscient Pharma
May 08, 2008 02:30 PM |
CHDN
,
CXR
,
EBAY
,
GOOG
,
MYGN
,
NCR
Analyst Comments: Lockheed Martin, Consolidated Graphics, Analog Devices, Corel, Analog Devices, Oscient Pharma, LoopNet, Broadcom
Apr 04, 2008 04:57 PM |
ADI
,
BRCM
,
CGX
,
CREL
,
CSGP
,
LMT
Analyst Comments: Oscient Pharmaceuticals, First Advantage, AmSurg, Anadys Pharmaceuticals, Dover Corp, Journal Register, Corel Corporation
Feb 21, 2008 03:50 PM |
CPE
,
FADV
,
OSCI
,
TRAK
Morning Earnings Summary
Feb 06, 2008 01:09 PM |
AHG
,
ALVR
,
ATMI
,
AVGN
,
BCE
,
BIIB
Analyst Comments: BASF Aktiengesellschaft, Allscripts Healthcare, Amphenol, Meredith, Amicus Therapeutics, Oscient Pharmaceuticals, Acergy S.A., I-Flow
Jan 21, 2008 10:19 AM |
ACGY
,
APH
,
BASFY
,
FOLD
,
IFLO
,
MDP
Analyst Comments: SanDisk, Joy Global, Ferrellgas Partners, Oscient Pharmaceuticals, Aladdin
Dec 12, 2007 04:39 PM |
ALDN
,
FGP
,
JOYG
,
OSCI
,
SNDK
More..
Two New Products and Hoping for Cornerstone
Sep 04, 2009 12:53 PM |
CRTX
,
OSCI
Oscient files for Chapter 11 bankruptcy protection
Jul 13, 2009 06:56 PM |
CRTX
,
OSCI
More..
Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
Jul 13, 2009 05:53 PM |
CRTX
,
OSCI
Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)
Jul 13, 2009 05:52 PM |
CRTX
,
OSCI
Oscient Pharmaceuticals Discontinues Sales Force Promotion for ANTARA and FACTIVE
Jun 11, 2009 07:03 PM |
OSCI
Oscient Pharmaceuticals Receives NASDAQ Letter Regarding Delay in Filing Form 10-Q
May 22, 2009 04:52 PM |
OSCI
Oscient Pharmaceuticals Files Form 12b-25 Notification of Late Filing for Form 10-Q for Quarterly Period Ended March 31, 2009
May 15, 2009 04:38 PM |
OSCI
Lazard Ltd Reports First-Quarter 2009 Results
Apr 28, 2009 07:55 AM |
ARIA
,
DOW
,
FTE
,
LAZ
,
NRG
,
OSCI
Oscient Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Financial Results
Mar 25, 2009 08:51 AM |
OSCI
Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
Mar 24, 2009 07:12 PM |
OSCI
NASDAQ Extends Temporary Suspension of Bid Price and Market Value of Publicly Held Shares Requirements; Oscient Compliance Period Extended to October 6, 2009
Mar 24, 2009 07:31 AM |
OSCI
Oscient Pharmaceuticals Restructures Commercial Organization
Feb 11, 2009 06:14 PM |
OSCI
More..
Form 3 BAB BIO VENTURES NV For: Jan 28 (10K)
May 29, 2009 06:15 PM
Form 4 OSCIENT PHARMACEUTICALS For: May 21 Filed by: GLG Partners LTD (10K)
May 26, 2009 10:28 PM
Form 4 OSCIENT PHARMACEUTICALS For: May 13 Filed by: DellaCamera Capital Management, LLC (10K)
May 15, 2009 06:51 PM
Form 4 OSCIENT PHARMACEUTICALS For: May 11 Filed by: DellaCamera Capital Management, LLC (10K)
May 13, 2009 08:47 PM
Form 4 OSCIENT PHARMACEUTICALS For: May 08 Filed by: DellaCamera Capital Management, LLC (10K)
May 12, 2009 07:41 PM
Form 4 OSCIENT PHARMACEUTICALS For: Apr 15 Filed by: DellaCamera Capital Management, LLC (10K)
Apr 17, 2009 07:05 PM
Form 4 OSCIENT PHARMACEUTICALS For: Mar 25 Filed by: DellaCamera Capital Management, LLC (10K)
Mar 27, 2009 06:23 PM
Form 3 OSCIENT PHARMACEUTICALS For: Nov 25 Filed by: GLG Market Neutral Fund (10K)
Jan 15, 2009 03:38 PM
Form 4 Michael Kao For: Nov 25 (10K)
Dec 23, 2008 08:25 PM
Form 3/A OSCIENT PHARMACEUTICALS For: Nov 25 Filed by: Michael Kao (10K)
Dec 17, 2008 06:56 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Bull
Bear
1
0
Avg. Long Term
Bull
Bear
1
0
Avg. Grade
More Details
Share Performance
Period
OSCI
Compare to S&P
YTD
-78.61 %
5.60 %
4 Weeks
-83.89 %
-84.27 %
12 Weeks
-70.38 %
-73.17 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
93.58 %
EPS Growth in Last Year:
93.52 %
Sales Growth in Last Quarter:
21.22 %
Sales Growth in Last Quarter:
4.44 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
